Skip to main content
CYPH
NASDAQ Life Sciences

Winklevoss Affiliate Reveals 19.9% Stake and Warrant Overhang Following Mining Fleet Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.074
Mkt Cap
$115.308M
52W Low
$0.26
52W High
$3.7
52W Position info
313% above low
Off High info
71% below high
Rel. Volume info
2.7× avg
Market data snapshot near publication time

CYPH has more than doubled off its 52-week low of $0.26 on elevated volume (2.7× avg).

Summary

Winklevoss affiliate WTI disclosed a 19.9% stake in Cypherpunk Technologies, including warrants for up to 159.35 million shares, subject to a 19.99% ownership cap that requires stockholder approval to exceed.


Key Events · Ownership and Investor Activity · CYPH

  • WTI Exercises Pre-Funded Warrants

    On August 17, 2026, WTI exercised pre-funded warrants to purchase 16,570,852 shares at $0.001 per share, bringing its direct holdings to 24,854,613 shares.

  • Warrant Overhang Disclosed

    WTI holds warrants exercisable for up to 159,350,186 shares: 58,877,766 pre-funded warrants, 43,290,042 APA pre-funded warrants, and 57,182,378 common warrants.

  • 19.99% Ownership Cap

    A beneficial ownership limitation prevents WTI from exercising warrants if it would own more than 19.99% of outstanding shares, currently capping its stake at 19.9%.

  • Stockholder Approval Sought

    Cypherpunk will seek stockholder approval to allow exercise of APA pre-funded warrants in excess of 5,377,442 shares (approximately 4.99% of pre-APA outstanding shares).


Analysis · CYPH · Life Sciences

Winklevoss Treasury Investments (WTI) now directly holds 24.85 million shares and has warrants exercisable for up to 159.35 million additional shares, but a 19.99% beneficial ownership cap prevents immediate exercise. The company will seek stockholder approval to lift the cap, creating a potential overhang of over 100 million shares. This follows the $33.33 million acquisition of a Zcash mining fleet from a Winklevoss affiliate, deepening the Winklevoss family's involvement in Cypherpunk.

At the time of this filing, CYPH was trading at $1.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $115.3M. The 52-week trading range was $0.26 to $3.70. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CYPH - Latest Insights

CYPH
Aug 19, 2026, 6:54 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $1.10 info
Change: +$0.0262 (+2%) info
Market Cap: $115.308M info
CYPH
Aug 18, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7269
Real-time Price: $1.10 info
Change: +$0.3731 (+51%) info
Market Cap: $115.308M info
CYPH
Aug 12, 2026, 7:16 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.710
Real-time Price: $1.10 info
Change: +$0.390 (+55%) info
Market Cap: $115.308M info
CYPH
Aug 12, 2026, 7:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.710
Real-time Price: $1.10 info
Change: +$0.390 (+55%) info
Market Cap: $115.308M info
CYPH
Aug 12, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.710
Real-time Price: $1.10 info
Change: +$0.390 (+55%) info
Market Cap: $115.308M info